Is FDA's revolving door open too wide?

Science. 2018 Jul 6;361(6397):21. doi: 10.1126/science.361.6397.21.
No abstract available

Publication types

  • News

MeSH terms

  • Advisory Committees / economics*
  • Conflict of Interest*
  • Drug Approval / economics*
  • United States
  • United States Food and Drug Administration